Revealing the Mechanisms of Shikonin Against Diabetic Wounds: A Combined Network Pharmacology and In Vitro Investigation
Conclusion: This study initially revealed the molecular mechanism of SHK in DW by multitarget and multipathway. The PI3K–AKT signaling pathway, MAPK signaling pathway, and AGE-RAGE signaling pathways may be the main pathways of SHK in treating DW.
Saved in:
| Main Authors: | Meng Tian, Junchao Wu, Qian Du, Jiale Han, Meng Yang, Xiang Li, Mingzhu Li, Xiaofeng Ding, Yeqiang Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/4656485 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An oxidative stress mechanism of shikonin in human glioma cells.
by: Jen-Tsung Yang, et al.
Published: (2014-01-01) -
Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells.
by: Wenjuan Li, et al.
Published: (2014-01-01) -
Preparation of RGD-modified liposomes encapsulated with shikonin and its targeted anti-melanoma effects
by: Hao Zhang, et al.
Published: (2025-05-01) -
Shikonin inhibits NLRP3 inflammasome activation and controls inflammatory disease
by: Jing Huang, et al.
Published: (2025-05-01) -
Ultrasound-assisted preparation of shikonin-loaded emulsions for the treatment of bacterial infections
by: Xiaomiao Cui, et al.
Published: (2025-04-01)